tirzepatide compounding deadline FDA confirms shortage is still over, gives compounders a grace period Legal Compounding of Tirzepatide Ends:

J., Temple, J

Recent and Emerging Anti-diabetes Targets

The published clinical data - 19.5% average body weight reduction at 52 weeks across 1,131 patients, published in a peer-reviewed journal (this outcome reflects a retrospective analysis of program completers and should not be interpreted as typical or guaranteed) - is a published peer-reviewed evidence base, which is uncommon among telehealth GLP-1 platforms

Weight loss could happen as early as few weeks in, for many, but people on WLMs should play the long game, regardless of results

After all, being informed not only prepares you for potential challenges but also ensures you're taking the safest approach to managing your weight